Document is current
Any future updates will be listed below
-
Authors
Korff, Kathrin https://orcid.org/0009-0005-4971-2417
Müller-Reif, Johannes B https://orcid.org/0000-0003-3454-2396
Fichtl, Dorothea
Albrecht, Vincent https://orcid.org/0009-0003-1985-7733
Schebesta, Alicia-Sophie
Itang, Ericka C M https://orcid.org/0000-0003-3387-2537
Winter, Sebastian Virreira
Holdt, Lesca M
Teupser, Daniel https://orcid.org/0000-0001-9843-0145
Mann, Matthias https://orcid.org/0000-0003-1292-4799
Geyer, Philipp E https://orcid.org/0000-0001-7980-4826
-
Funding
Funding for this research was provided by:
Max-Planck-Gesellschaft
Bundesministerium für Bildung und Forschung (3LW0245)
Bill and Melinda Gates Foundation (INV-058348)
German Center for Child and Adolescent Health (01GL2406D)
- License Information
-
More Information
Article History
Received: 8 May 2025
Revised: 27 August 2025
Accepted: 28 August 2025
First Online: 12 September 2025
Disclosure and competing interests statement
: Matthias Mann is an indirect investor in Evosep, and Philipp Geyer is a founder and employee of ions.bio. The remaining authors declare no competing interests.
